| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 0.06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |